Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
759 ADPORT-601 (TT-10–101): first-in-human study of adenosine 2A (A2A) and adenosine 2B (A2B) receptor antagonists in participants with selected advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.